CMS Starts Collecting Physician Payment Data from Medical Device and Pharmaceutical Manufacturers for Public Website

The public will soon have better insight into the amount of funds flowing to healthcare providers from pharmaceutical and medical device companies. On February 18, 2014, CMS began collecting data from drug and device manufacturers on payments made to healthcare providers, as required under the Physician Payments Sunshine Act. During the first phase of the program, companies will submit data on payments made to healthcare providers, including gifts, consulting fees, and research activities. Previously, CMS said that it would release the data on a public website by September 30, 2014. Excessive payments to health care providers may not be sufficient to trigger federal Anti-kickback Statute (AKS) prosecutions. Whistleblowers are usually needed to fully evidence the necessary corporate intent to trigger AKS liability.

OUR PROMISE Being a healthcare whistleblower can feel like David taking on Goliath. We help level the playing field.

Our law practice is dedicated exclusively to representing healthcare whistleblowers who are willing to take a stand against unscrupulous corporations that are ripping off our government. Whether the fraud involves __________, we pride ourselves on unparalleled level of service, support and legal assistance for our clients.
Contact Us

Contact Us

The more detailed the response, the more likely it is that we will be able to evaluate and determine if your potential False Claims Act case falls within our case requirements. If it does, WE WILL RESPOND TO YOU WITHIN 24 HOURS. (Names of potential defendants are not necessary at this point, should you feel more comfortable omitting them.) By law, all communications to us are 100% confidential.

Please enable JavaScript in your browser to complete this form.
No. of Employees at the Company?


Please read the following statement and then click “Send Form”:

Any response to your e-mail will be solely to communicate about our possible representation of you under the qui tam provisions of the False Claims Act. All e-mails submitted to us, whether we take your case or not, are 100% confidential. If we do not respond to your e-mail, then you have communicated information which we cannot address because it appears to fall outside of the False Claims Act or our case requirements.